Skip to main content

Day: April 9, 2026

Abercrombie & Fitch and Sperry Reunite After Six Decades, Reviving a Partnership From the 1930s

The original retail partner that helped introduce Sperry Top Siders across America returns with a modern capsule rooted in authentic historySperry x Abercrombie collaborate on apparel and footwear capsule rooted in authentic, shared historyApril 9, 2026Sperry x Abercrombie collaborate on apparel and footwear capsule rooted in authentic, shared historyApril 9, 2026Sperry x Abercrombie collaborate on apparel and footwear capsule rooted in authentic, shared historyApril 9, 2026Sperry x Abercrombie collaborate on apparel and footwear capsule rooted in authentic, shared historyApril 9, 2026Sperry x Abercrombie collaborate on apparel and footwear capsule rooted in authentic, shared historyApril 9, 2026NEW ALBANY, Ohio, April 09, 2026 (GLOBE NEWSWIRE) — Today, Abercrombie & Fitch (“Abercrombie”),...

Continue reading

Wetour Robotics Appoints Chief Technology Officer to Lead Orchestra Physical AI and Wearable Robotics Platform and Chief Marketing Officer to Oversee Brand Strategy and Go-to-Market Execution

Austin, TX, April 09, 2026 (GLOBE NEWSWIRE) — Wetour Robotics Limited (NASDAQ: WETO) (“Wetour Robotics” or the “Company”), a Physical AI infrastructure and wearable robotics company headquartered in Austin, Texas, today announced the appointment of Bin Lian as Chief Technology Officer to lead the development of the Company’s Orchestra human-machine interaction platform and Yu-Tien Chiu as Chief Marketing Officer. Mr. Lian holds a Bachelor of Science in Materials Physics from the University of Science and Technology of China (USTC), one of China’s top-ranked research universities, and is a Ph.D. candidate in Mechanical Engineering at The University of Texas at Austin. His academic training spans materials science, mechanical systems, and computational methods — a cross-disciplinary foundation...

Continue reading

LivTech Acquires Alora Healthcare Systems, Further Expanding Leadership in Home-Based Care Technology

Strategic acquisition integrates AI-powered EMR and clinical automation to address home healthcare challenges Knoxville, TN, April 09, 2026 (GLOBE NEWSWIRE) — LivTech, a leading provider of comprehensive healthcare tech solutions specifically designed for long-term post-acute care, today announced the acquisition of Alora Healthcare Systems (Alora), a premier developer of cloud-based, AI-enhanced home health care software. This strategic acquisition unites LivTech’s expansive operational ecosystem with Alora’s specialized clinical and compliance expertise, creating a unified powerhouse designed to address the critical challenges of the home healthcare market. This acquisition and expansion into home health positions LivTech as a category leader within the in-home space and a provider of solutions across the entire long-term post-acute...

Continue reading

Helport AI and QuickCEP Forge Strategic Alliance, Aiming to Accelerate AI Workforce Infrastructure for Global Brands

Partnership Integrates Helport AI’s “AI Labor System” with QuickCEP’s AI Agent Platform, With the Goal of Creating a “Software + AI Workforce” Infrastructure that Delivers Performance-Based Outcomes SAN DIEGO and SINGAPORE, April 09, 2026 (GLOBE NEWSWIRE) — Helport AI Limited (NASDAQ: HPAI) (“Helport AI” or the “Company”), a global technology company providing enterprise clients with intelligent customer communication software and services powered by artificial intelligence (“AI”), today announced a strategic partnership with QuickCEP, a leading AI customer interaction agent platform built for cross-border and global brands. The two companies intend to jointly develop a “One-Stop, Fully Managed AI Agent Solution” for global brands and e-commerce enterprises. The resulting solution is expected to combine Helport AI’s proprietary...

Continue reading

Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing Strategic Partnership with WuXi XDC

CEO Abizer Gaslightwala discusses the Company’s strategic partnership with WuXi XDC and its implications for platform validation and development acceleration Company highlights accelerated IND timeline for AKTX-101 and positioning within the rapidly evolving ADC landscape Watch the “What This Means” video here TAMPA and LONDON, April 09, 2026 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulating payloads, today announced that Abizer Gaslightwala, Director, President and CEO of Akari Therapeutics, participated in a Virtual Investor “What This Means” interview focused on the Company’s recently announced strategic partnership with WuXi XDC. As part of the segment, Mr. Gaslightwala discussed how the strategic partnership...

Continue reading

Data Storage Corporation Reschedules Fiscal 2025 Business Update Call for April 14, 2026 at 11:00 am Eastern Time

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), today announced that it has rescheduled its business update conference call for 11:00 a.m. Eastern Time on April 14, 2026, to discuss the Company’s financial results for the 2025 fiscal year which ended December 31, 2025, as well as corporate progress and other developments. The conference call will be available via telephone by dialing toll-free 877-407-9219 for U.S. callers or for international callers +1-412-652-1274. A webcast of the call may be accessed at  DTST Business Update Call or on the Company’s News & Events section of the website,  www.dtst.com/news-events. A webcast replay of the call will be available on the Company’s website (www.dtst.com/news-events) through October 14, 2026. A telephone replay...

Continue reading

Immix Biopharma to Participate in the Jefferies Global Healthcare Conference

LOS ANGELES, CA, April 09, 2026 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will participate and host institutional investor meetings at the Jefferies Global Healthcare Conference being held June 2-4, 2026 in New York, NY. The Company will be available for one-on-one meetings during the conference. Interested investors should contact their Jefferies representative to request meetings. A link to access the replay, when available, will be posted to the Immix website on the Presentation & Events page under the Investors section. About Immix Biopharma, Inc.Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is the global leader in relapsed/refractory AL Amyloidosis. AL Amyloidosis is a devastating disease where...

Continue reading

EpicQuest Education Announces New Revenue Stream via Davis University’s High School Acceleration and Pathway Programs

TOLEDO, Ohio, April 09, 2026 (GLOBE NEWSWIRE) — EpicQuest Education Group International Limited (Nasdaq: EEIQ), (“EpicQuest Education”, “EEIQ” or the “Company”), a provider of higher education for domestic and international students in the US, Canada and the UK,  today announced that its owned and operated Davis University (“Davis”) recently entered into agreements with four Canadian high schools for high school students to enter into high school accelerated and University pathway programs by enrolling in Davis’ first-year online courses of its Bachelor of Science in Business program. “The agreements represent a potential new revenue stream for the Company as each student can take a significant number of courses at Davis University, while it also represents a recruitment pool for our full-time Davis degree programs,” said Diane...

Continue reading

ZenaTech Announces its 21st Acquisition, Expanding National Drone as a Service Network and Pacific Northwest Footprint to Serve Business and Government

VANCOUVER, British Columbia, April 09, 2026 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, today announces that it has completed its 21st acquisition, adding to its national expansion of Drone as a Service U.S. locations. The acquisition of Andy Paris & Associates, a Lake Oswego, Oregon-based, long-established land surveying firm, strengthens ZenaTech’s customer base and presence in the Portland area, accelerating drone-enabled inspections, surveys, and other services in the Pacific Northwest region for business and government customers. “Strengthening the Pacific Northwest operations puts us right at the intersection...

Continue reading

When Wall Street and Blockchain Converge: Fairmint Acquires The RWA Desk

With over $1B in assets already processed, Fairmint is accelerating the push of onchain equity adoption by bringing traditional finance leaders to the same rooms as blockchain innovators NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) — Fairmint, a pioneer in onchain equity infrastructure, announced today the acquisition of The RWA Desk, a New York City private events and media platform where Wall Street leaders at the intersection of finance and blockchain convene. As private and public equity converge, the teams will bring Fairmint’s innovative infrastructure directly to the people allocating capital every day. As the onchain representation of traditional financial instruments surpasses $300 billion in 2026, Fairmint is positioning itself as the primary rail for the next wave of institutional equity. The company is an SEC-registered...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.